跳至主要内容
临床试验/EUCTR2011-002727-18-NL
EUCTR2011-002727-18-NL进行中(未招募)不适用

The effects of switching antidepressants on endoxifen exposure - Switch study

未提供0 个研究点目标入组 13 人开始时间: 2011年7月6日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
13

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Histological or cytological confirmed diagnosis of breast cancer, for which treatment with tamoxifen monotherapy is indicated (to be evaluated by the treating physician);
  • - Use of tamoxifen monotherapy for at least 4 weeks (to guarantee steady-state) and willing to continue the treatment until the end of the study;
  • - Concomitant use of paroxetine for at least 14 days;
  • - Age >18 years;
  • - WHO performance < 1
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 13
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Pregnant or lactating patients
  • - Patients with a history of suicide attempts or current suicidal ideation;
  • - Contra-indications for venlafaxine and/or escitalopram use;
  • - Patients with Congenital Long QT Syndrome (CLQTS).

研究者

发起方
未提供

相似试验

The effects of switching antidepressants on... | 临床试验